뒤로
Infant Bacterial Therapeutics AB (publ)(IFTBF) 가격
IFTBF 주가 차트
IFTBF 수입
Infant Bacterial Therapeutics AB (publ)
$5.47
0%
$0
오늘 기준:Feb 10, 13:37:27 GMT-5
Earnings FAQ
IFTBF의 최근 주당순이익(EPS)은 예상과 비교하여 어떤가요?
Infant Bacterial Therapeutics AB (publ) IFTBF의 지난 분기 매출 실적은 어땠나요?
Infant Bacterial Therapeutics AB (publ)의 매출 추정치는 얼마인가요?
Infant Bacterial Therapeutics AB (publ)의 수익 품질 점수는 얼마인가요?
Infant Bacterial Therapeutics AB (publ)는 언제 수익을 보고하나요?
Infant Bacterial Therapeutics AB (publ)의 예상 수익은 얼마인가요?
Infant Bacterial Therapeutics AB (publ)은 수익 기대치를 충족했나요?
주요 통계
이전 종가
--
시가
--
일일 범위
-
52주 범위
$4.78 - $8.2
거래량
--
평균 거래량
1.0K
EPS(TTM)
--
배당수익률
--
시가총액
--
INFANT BACTERIAL THERAPEUTICS A란 무엇인가요?
Infant Bacterial Therapeutics AB is a clinical stage pharmaceutical company, which engages in the development of drugs for the treatment of rare diseases affecting premature infants. The company is headquartered in Stockholm, Stockholm and currently employs 10 full-time employees. The company went IPO on 2016-03-29. The firm develops drugs that meet the needs of the premature infant. The Company’s focus is on clinical development of IBP-9414, a drug candidate containing Lactobacillus reuteri, in the prevention of necrotizing enterocolitis (NEC), a fatal disease that affects premature infants.